720
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

CircMMD_007 promotes oncogenic effects in the progression of lung adenocarcinoma through microRNA-197-3p/protein tyrosine phosphatase non-receptor type 9 axis

, , , , &
Pages 4991-5004 | Received 19 Dec 2021, Accepted 31 Jan 2022, Published online: 14 Feb 2022

References

  • Chalela R, Curull V, Enríquez C, et al. Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy. J Thorac Dis. 2017;9(7):2142–2158.
  • Shukla S, Evans JR, Malik R, et al. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma. J Natl Cancer Inst. 2017;109(1). DOI:10.1093/jnci/djw200
  • Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018;9(2):117.
  • Yu K-H, Berry GJ, Rubin DL, et al. Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma. Cell Syst. 2017;5(6):620–627.e623.
  • Gillette MA, Satpathy S, Cao S, et al. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell. 2020;182(1):200–225 e235.
  • Calvayrac O, Pradines A, Pons E, et al. Molecular biomarkers for lung adenocarcinoma. Eur Respir J. 2017;49(4):1601734.
  • Chen Z, Ju H, Zhao T, et al. hsa_circ_0092306 Targeting miR-197-3p Promotes Gastric Cancer Development by Regulating PRKCB in MKN-45 Cells. Mol Ther Nucleic Acids. 2019;18:617–626.
  • Zhao J, Li L, Wang Q, et al. CircRNA Expression Profile in Early-Stage Lung Adenocarcinoma Patients. Cell Physiol Biochem. 2017;44(6):2138–2146.
  • Wang C, Tan S, Liu WR, et al. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma. Mol Cancer. 2019;18(1):134.
  • Dudekula DB, Panda AC, Grammatikakis I, et al. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13(1):34–42.
  • Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42( Database issue):D92–97.
  • Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–D131.
  • Vlachos IS, Vergoulis T, Paraskevopoulou MD, et al. DIANA-mirExTra v2.0: uncovering microRNAs and transcription factors with crucial roles in NGS expression data. Nucleic Acids Res. 2016;44(W1):W128–134.
  • Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4. DOI:10.7554/eLife.05005
  • Jiang Y, Wei T, Li W, et al. Circular RNA hsa_circ_0002024 suppresses cell proliferation, migration, and invasion in bladder cancer by sponging miR-197-3p. Am J Transl Res. 2019;11(3):1644–1652.
  • Sun D, Wang G, Xiao C, et al. Hsa_circ_001988 attenuates GC progression in vitro and in vivo via sponging miR-197-3p. J Cell Physiol. 2020;236(1):612–624.
  • Lerman G, Sharon M, Leibowitz-Amit R, et al. The crosstalk between IL-22 signaling and miR-197 in human keratinocytes. PLoS One. 2014;9(9):e107467.
  • Xu F, Li H, Hu C. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer. Biosci Rep. 2019;39(7). DOI:10.1042/BSR20180551
  • Yang T, Li H, Chen T, et al. LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis. Mol Cells. 2019;42(3):270–283.
  • Ni JS, Zheng H, Huang ZP, et al. MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma. Oncol Lett. 2019;17(2):2317–2327.
  • Zhu J, Li H, Ma J, et al. PTPN9 promotes cell proliferation and invasion in Eca109 cells and is negatively regulated by microRNA-126. Oncol Lett. 2017;14(2):1419–1426.
  • Wang D, Cheng Z, Zhao M, et al. PTPN9 induces cell apoptosis by mitigating the activation of Stat3 and acts as a tumor suppressor in colorectal cancer. Cancer Manag Res. 2019;11:1309–1319.
  • Hong Y, Liang H, Uzair Ur R, et al. miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer. Sci Rep. 2016;6(1):37421.
  • Yuan T, Wang Y, Zhao ZJ, et al. Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells. J Biol Chem. 2010;285(20):14861–14870.
  • Kim M, Morales LD, and Jang IS, et al. Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling. Int J Mol Sci. 2018;19(9):1–19.
  • Ma X, Shi W, Peng L, et al. MiR-96 enhances cellular proliferation and tumorigenicity of human cervical carcinoma cells through PTPN9. Saudi J Biol Sci. 2018;25(5):863–867.
  • Hu B, Yan X, Liu F, et al. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression. Pathol Oncol Res. 2016;22(3):555–565.